Roche, the Swiss pharmaceutical company, has warned that the UK risks losing its lead in medical research after leaving the European Union.
The Swiss group called for Britain to move quickly to replace European regulations with rules that give patients access to innovative treatments or else risk delays in developing crucial medicines.
The future of local drug regulation was "my biggest worry in the UK", said Severin Schwan, Roche's chief executive.
Image: http://www.swissinfo.ch
